Rx Product News (August 2016)

August 30th 2016

Read about the new Rx Products featured in August.

AMELUZ

Marketed by:Biofrontera

Indication:Ameluz (BF-200 ALA) is a photo- dynamic therapy treatment for mild to moderate actinic keratosis on the face and scalp. The product should be used in conjunction with the BF-RhodoLED medical device and administered under the supervision of a health profes- sional familiar with photodynamic therapy. Ameluz is set to launch by September 2016.

Dosage Form:Topical gel: 78 mg/g For More

Information:biofrontera.com

SERNIVO SPRAY

Marketed by:Promius Pharma, LLC

Indication:Sernivo (beta- methasone dipropionate) is FDA-approved for the treatment of mild to moderate plaque psoriasis in patients 18 years or older. The commercial launch of the product is planned for the coming quarter. Dosage Form: Spray: 0.05%

For More Information:drreddys.com

LINEZOLID TABLETS 600 MG

Marketed by: Camber Pharmaceuticals Compare to: Zyvox (Pfizer) Indication: Camber Pharmaceuticals has launched Linezolid Tablets, the generic equivalent to Zyvox, in a 600-mg tablet strength. The drug is indicated to treat several types of bacterial infections, including pneumonia, skin infections, and other antibiotic-resistant infections.

Dosage Form:Tablets: 600 mg

For More Information: camberpharma.com

Related Content